Activity-dependent changes in gene expression in schizophrenia human-induced pluripotent stem cell neurons

JAMA Psychiatry

Volumn 73, Issue 11, 2016, Pages 1180-1188

  Roussos, Panos ^a   Guennewig, Boris ^a   Kaczorowski, Dominik C ^a   Barry, Guy ^a   Brennand, Kristen J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHLORIDE; RNA;

ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; GENE EXPRESSION; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NERVE CELL; PLURIPOTENT STEM CELL; SCHIZOPHRENIA; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION STUDY; GENETIC TRANSCRIPTION; GENETIC VARIATION; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SYNAPTIC TRANSMISSION; UPREGULATION;

DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REFERENCE VALUES; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84997693743     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2575     Document Type: Article

References (31)

1. SchizophreniaWorking Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-Associated genetic loci. Nature. 2014;511(7510):421-427.
2. Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506(7487):179-184.
3. Girard SL, Gauthier J, Noreau A, et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 2011;43(9):860-863.
4. Gulsuner S, Walsh T, Watts AC, et al; Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 2013;154(3): 518-529.
5. McCarthy SE, Gillis J, Kramer M, et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry. 2014;19(6):652-658.
6. Xu B, Ionita-Laza I, Roos JL, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet. 2012;44 (12):1365-1369.
7. Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506(7487):185-190.
8. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature. 2013;493(7432):327-337.
9. Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473(7346):221-225.
10. Brennand K, Savas JN, Kim Y, et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry. 2015;20(3): 361-368.
11. Benjamini YH. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57 (1):289-300.
12. Ashburner M, Ball CA, Blake JA, et al; The Gene Ontology Consortium. Gene ontology: Tool for the unification of biology. Nat Genet. 2000;25(1):25-29.
13. Fabregat A, Sidiropoulos K, Garapati P, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2016;44(D1):D481-D487.
14. Gray KA, Yates B, Seal RL, WrightMW, Bruford EA. Genenames.org: The HGNC resources in 2015. Nucleic Acids Res. 2015;43(Database issue): D1079-D1085.
15. Kirov G, Rees E, Walters JT, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2014;75(5):378-385.
16. De Rubeis S, He X, Goldberg AP, et al; DDD Study; Homozygosity Mapping Collaborative for Autism; UK10K Consortium. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209-215.
17. Jiang YH, Yuen RK, Jin X, et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet. 2013;93(2):249-263.
18. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485(7397):242-245.
19. Iossifov I, ORoak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515(7526): 216-221.
20. de Ligt J, Willemsen MH, van Bon BWM, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367 (20):1921-1929.
21. Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511 (7509):344-347.
22. Hamdan FF, Srour M, Capo-Chichi J-M, et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet. 2014;10(10): e1004772.
23. Rauch A, Wieczorek D, Graf E, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: An exome sequencing study. Lancet. 2012;380(9854): 1674-1682.
24. Allen AS, Berkovic SF, Cossette P, et al; Epi4K Consortium; Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217-221.
25. Appenzeller S, Balling R, Barisic N, et al; EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet. 2014;95(4):360-370.
26. Lin Y, Bloodgood BL, Hauser JL, et al. Activity-dependent regulation of inhibitory synapse development by Npas4. Nature. 2008;455(7217): 1198-1204.
27. Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies [published online February 19, 2016]. bioRxiv. doi:10.1101/040170.
28. Hook V, Brennand KJ, Kim Y, et al. Human iPSC neurons display activity-dependent neurotransmitter secretion: Aberrant catecholamine levels in schizophrenia neurons. Stem Cell Reports. 2014;3(4):531-538.
29. Barros CS, Franco SJ, Mler U. Extracellular matrix: functions in the nervous system. Cold Spring Harb Perspect Biol. 2011;3(1):a005108.
30. Berretta S. Extracellular matrix abnormalities in schizophrenia. Neuropharmacology. 2012;62(3): 1584-1597.
31. Yoon K-J, Nguyen HN, Ursini G, et al. Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. Cell Stem Cell. 2014;15(1):79-91.